Speaker illustration

Mr Julian Merz

University of Freiburg, Freiburg (Germany)

Knockout of purinergic receptor Y13 (P2Y13) results in an improved outcome of metabolic syndrome in mice

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes

Session: Advances in Lipids and Cardiovascular Diseases

Thumbnail

Post-myocardial infarction activation of P2X7 dependent inflammasome is crucial to develop an appropriate scar integrity

Event: ESC CONGRESS 2019

Topic: Fibrosis

Session: Molecular mechanisms of cardiovascular inflammation

Thumbnail

Knockout of purinergic receptor Y13 (P2Y13) results in an improved outcome in metabolic syndrome in mice

Event: ESC CONGRESS 2019

Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes

Session: Metabolic interfaces in vascular disease

Thumbnail

The role of the purinergic receptor p2x7 in the pathogenesis of atherosclerosis

Event: ESC CONGRESS 2017

Topic: Atherosclerosis

Session: Atherogenesis - New mechanisms

Thumbnail

ESC 365 is supported by

logo Novo Nordisk